Hi ,
In 2012, our co-founder Trent Scanlen was diagnosed with Non-Hodgkin Lymphoma.
During treatment, he teamed up with longtime friend Dr Harry Weisinger—who had survived the same illness—to rethink inflammation, recovery, and long-term health.
Together, they built KURK.
This month, Men’s Health Australia featured Trent’s journey—from cancer and chemo to building a product that’s now trusted by thousands.
“It [Lymphoma] was the clear catalyst for me to understand that I had to prioritise my health.”
Read the full blog post
We’re proud to share where it all started—and why what we do matters.
Thanks for being part of the journey.
— The KURK Team
In 2012, our co-founder Trent Scanlen was diagnosed with Non-Hodgkin Lymphoma.
During treatment, he teamed up with longtime friend Dr Harry Weisinger—who had survived the same illness—to rethink inflammation, recovery, and long-term health.
Together, they built KURK.
This month, Men’s Health Australia featured Trent’s journey—from cancer and chemo to building a product that’s now trusted by thousands.
“It [Lymphoma] was the clear catalyst for me to understand that I had to prioritise my health.”
Read the full blog post
We’re proud to share where it all started—and why what we do matters.
Thanks for being part of the journey.
— The KURK Team
|
You received this email from Kurk. If you would like to unsubscribe, click here. |
